AzTrials
AzTrials

Colorectal CancerNCT04093687

Towards Painless Colonoscopy

A study testing Endoscopist's training in people with Colorectal Cancer, run by Maria Sklodowska-Curie National Research Institute of Oncology at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

One of the major barriers to CRC screening participation is a negative perception of colonoscopy as a painful and unpleasant procedure. Previously, by monitoring patient-reported outcomes as one of the colonoscopy quality performance measures, the investigators identified the endoscopist as the single, most important… Read more about this study

Who is it for?
Any age
Conditions the study is for
Colorectal Cancer
What is being tested?
Endoscopist's training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 sitePoland
Study dates
Nov 2019to Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Endoscopists contributing to Polish Colonoscopy Screening Program
  • Endoscopists classified as underperformers and average performers, i.e. endoscopists performing above the adjusted mean rate of painful colonoscopies (with high adjusted painful colonoscopy rate), outside of confidence interval of 99% based on the number of performed colonoscopies, and performing inside the confidence interval of 99%, respectively.
  • Colonoscopy volume of at least 100 colonoscopies/year for at least 2 years prior to the study inclusion

Who cannot join

  • Endoscopists from the PCSP coordinating centre
  • Endoscopists who have participated in the first phase of the study
  • Endoscopists classified as overperformers, i.e. performing below the adjusted mean rate of painful colonoscopies (with high adjusted painful colonoscopy rate), outside of confidence interval of 99% based on the number of performed colonoscopies.

Trial locations and contacts

1 site in 1 country.

Marek Bugajski, MD, PhD contact

22-5463-044

marek.bugajski@gmail.com

Poland1 site
  • Maria Sklodowska-Curie Institute - Oncology Center

    Warsaw

    Marek Bugajski, MD, PhD, 22-5463-044, marek.bugajski@gmail.com

    Michal F Kaminski, MD, PhD, 22-5463-044, mfkaminski@gmail.com

Other trials in Poland

About this study

Official title: Towards Painless Colonoscopy: a Dedicated Training to Decrease the Rate of Painful Colonoscopy - a Randomized Controlled Trial

One of the major barriers to CRC screening participation is a negative perception of colonoscopy as a painful and unpleasant procedure. Previously, by monitoring patient-reported outcomes as one of the colonoscopy quality performance measures, the investigators identified the endoscopist as the single, most important risk factor for painful colonoscopy. Therefore, the investigators propose a randomized controlled trial to analyse the effectiveness of directed training on the endoscopists painful colonoscopy rate.

The study will be conducted in two phases: endoscopist categorization and design of training (I) and randomized controlled trial evaluating training effectiveness (II).

Read more

Phase I will include endoscopists from Polish Colonoscopy Screening Programme (PCSP) willing to participate. Volunteers will be divided into underperformers, average performers and overperformers, based on their painful colonoscopy rate (obtained from PCSP database records) and will be invited to take part in the initial workshop focused on pain reduction during colonoscopy (conducted in a similar fashion to Train Colonoscopy Leaders (TCL) workshop, aiming at ADR improvement).

On the basis of the differences in performance between over- and underperformers, categories of importance, target scores and a questionnaire for the assessment of factors for improvement will be developed.

In Phase II, endoscopists from PCSP screening centres previously categorized as underperformers and average performers will be randomized in 1:1 ratio either to control (no intervention) or intervention arm.

The subjects in the control arm will not be trained or informed about study participation.

The endoscopists assigned to the intervention arm will be invited to take part in one training session designed in Phase I of the study (according to the evaluation questionnaire from Phase I). Willing overperformers will be asked to participate in the training as teachers. The training session will be divided into two parts: theoretical - presentation of research on painless colonoscopy - and practical - colonoscopy performance with commentary. Subjects matched 1:1 with trainers will take part in such a session, supervised by the study coordinator.

Each endoscopist who underwent training in the second phase of the study will be sent a written, customized feedback on changes after the intervention and information about factors to improve (as per evaluation questionnaire from Phase I of the study). All endoscopists enrolled into Phase II will be followed through PCSP database for the endpoint of painful colonoscopy rate; the intervention arm will be compared with the control group at 6 and 12 months after feedback in order to investigate whether the adjusted painful colonoscopy rate improved as a result of the intervention.

Read the detailed description

Background and study rationale:

Colorectal cancer (CRC) is the second leading cause of death from cancer in Europe. Several modalities of CRC screening exist, with each screening modality including colonoscopy either as a primary or secondary test (following positive sigmoidoscopy or faecal occult blood test). Unfortunately, patients perceive colonoscopy as a painful and unpleasant procedure. This is one of the major barriers for participation in CRC screening, particularly since those being screened are usually healthy and asymptomatic. Monitoring patient-reported outcomes is one of the understudied performance measures for quality in colonoscopy according to recent guidelines.

Since 2014, the Polish Colorectal Cancer Screening Programme (PCSP) has routinely used the Gastronet questionnaire to measure patient-reported outcomes. The Gastronet is a Norwegian quality-assurance programme that was initiated in 2003. Patients fill in the questionnaire at home 1 day after colonoscopy and send it back via traditional mail. Questions on pain are answered on a 4-point scale: no pain, slight pain, moderate pain, and severe pain. This scale has been validated previously.

In previous analysis, the investigators have identified several, independent risk factors for painful colonoscopy. However, the single, most important risk factor for painful colonoscopy was the endoscopist himself. This was shown with regards to pain rates adjusted for all factors found relevant in multivariate models (including sedation). The variation among endoscopists was observed as 11- to 23-fold difference in adjusted painful colonoscopy rate. Adjusting for most measurable variables allowed us to cancel the effect of patient selection or other technical issues (endoscope used etc.) and attribute the observed differences, with high probability, to the individual, unquantifiable technical and nontechnical skills possessed by each endoscopist. These skills comprise both the interpersonal skills required to establish a meaningful patient-endoscopist relationship and individual manual skills.

Among modifiable factors, propofol sedation resulted in better procedure tolerance. In most countries, the propofol sedation must be performed by an anaesthesiologist. This practice generates higher costs and reduces colonoscopy unit capacity, as it requires more time, resources, and personnel. Moreover, sedated colonoscopy poses a greater risk of sedation-related (e.g., pneumonia and cardiovascular events) and procedure-related (e.g., bowel perforation and bleeding) complications. What was surprising, sedation based on combination of opioids and benzodiazepines (regarded devoid of aforementioned downsides of propofol sedation) did not improve colonoscopy tolerance in comparison to no sedation at all. This observation led us to suggesting that only propofol sedation should be regarded as effective in case of colonoscopy.

Taking into account the fact that propofol sedation is not a universal and ultimate remedy to increase colonoscopy satisfaction, directed training should be considered to reduce the rate of painful colonoscopies. Technical and nontechnical skills can be either improved or developed with such training, which should focus not only on reducing the odds for pain during, but also after colonoscopy. Such training is necessary especially in cases of countries with limited colonoscopy and/or anaesthesia services capacity.

Up to date, there are no studies assessing the efficacy of training, aiming at reducing the odds of painful colonoscopy. Moreover, there is no existing data on how such training should be designed. Therefore the investigators propose a two-step study:

  1. to design a dedicated training program and
  2. to evaluate effectiveness of such training in a randomized controlled trial.

Hypothesis:

Dedicated training reduces the painful colonoscopy rate.

Aim:

To investigate, whether directed training leads to reduction in painful colonoscopy rate.

Methods:

The study will be conducted in two phases:

  1. Endoscopist categorization based on their performance with regards to colonoscopy pain (under- over- and average performers), according to feedback provided for colonoscopies before study entry and design of training II. Randomized controlled trial evaluating training effectiveness. Phase I - training (intervention) design The first phase of the study consists of the endoscopist categorization, observation of work and workshop with selected PCSP endoscopists to design the training program.

First of all, to categorize endoscopists, the investigators will build multivariate models (as in our previous work) for dataset from years 2014-2018 for pain during endoscopy, allowing us to divide endoscopists into three categories:

  1. Underperformers: endoscopists performing worse than expected (with adjusted painful colonoscopy rate higher than mean).
  2. Overperformers: endoscopists performing better than expected (with adjusted painful colonoscopy rate lower than mean).
  3. Average performers: endoscopists performing inside the confidence interval for mean adjusted painful colonoscopy rate.

For the purpose of creating dedicated assessment questionnaire, the investigators will adapt existing DOPS questionnaire, with tailored modifications (utilising such categories as loop formation and loop reduction, going through flexures, time to caecum, utilisation of additional techniques (change of position, assistance), non-technical skills (communicating with a patient), time slot for colonoscopy, equipment, assistant involvement, sedation etc.) based on experts' opinions, working in PCSP coordinating centre. First, each expert endoscopist will be asked to suggest 5 key, specific elements that are crucial for painless colonoscopy. These elements will be compiled into one list and divided into appropriate domains (pre-procedure, technical considerations, non-technical skills, infrastructure, etc.). The elements will be formatted into questions with binary answer (yes/no). Next, the investigators will perform visits at willing sites, where screening colonoscopies are done by up to 5 under- or overperformers. During such visits, endoscopists will be assessed during their routine work, in friendly environment, utilising the questionnaire, however the purpose of the visits is to modify the questionnaire, to include aspects not initially covered.

Phase II - randomized controlled trial The second phase of the study consists of the randomized controlled trial evaluating the effectiveness of the training developed in Phase I, based on constructed questionnaire. Endoscopists previously categorized as underperformers and average performers from PCSP screening centres will be randomized in 1:1 ratio either to control arm (practice as usual) or training intervention arm. Overperformers will be asked to participate in training sessions as regular participants, however overperformers will not be randomized and treated as study subjects; after intervention, they will be informed about the study design and training session purpose. The endoscopists assigned to the training intervention group will be invited to take part in one training session, similar to the one introduced in Train Colonoscopy Leaders trial (evaluation questionnaire from Phase I will be used). After the training session, each endoscopist from the intervention arm will be sent a written report, including customized feedback on performance and suggested areas of improvement (on the basis of evaluation questionnaire from Phase I of the study). Endoscopists from the intervention group will be followed through PCSP database and will be compared with the control group at 6 and 12 months after feedback. Endoscopists from the control group will not be trained nor will they be informed about study participation. They will receive a reminder, that dedicated report on painful colonoscopy rate is provided in the PCSP database and they will be monitored for endpoints through PCSP database.

Being tested
Endoscopist's training
Keywords
Colorectal Cancer Screening, Screening Colonoscopy, Pain During Colonoscopy
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopist's trainingOther

    The training session will be divided into two parts: theoretical and practical. Trainees will be blinded to the criterion of being chosen due to their performance status.

    During the first, theoretical part, the body of research on the phenomenon of colonoscopy pain will be presented. Aspects on how to deliver a painless colonoscopy (patient characteristics, insertion technique, endoscope characteristics, non-technical skills, additional manoeuvres) will be discussed. This part will be based on the findings from Phase I.

    The second, practical part of the training, will consist of a one-day session of 7 colonoscopies. Participants will be matched with each other. Each participant, will perform one colonoscopy with an oversight of a matched partner, then in turn oversee the colonoscopy of another participant. The rest of the participants will observe a live transmission of each colonoscopy in a separate room, with a commentary from study coordinator.

Study groups in NCT04093687
Study groupRoleWhat they receive
Intervention ArmExperimentalThe intervention will consist of one training session, focusing on technical and non-technical aspects identified in the study Phase I (according to the evaluation questionnaire). The training will be conducted by a team consisting of (i) supervisors (researchers) and (ii) teachers experienced in the previous trial (Train-Colonoscopy-Leaders course - TCL; this methodology has already been evaluated (citation)). There will be 7 trainees per session: 1 under-, 4 average and 2 overperformers. The training session will be divided into two parts: theoretical and practical. During the first, theoretical part of the training, the body of research on the phenomenon of colonoscopy pain will be presented. The second, practical part of the training, will consist of a one-day session of 7 colonoscopies. Each average and underperforming endoscopist who underwent training in the randomized phase will receive a written, customized feedback on his/her performance during the training session.
Receives: Other: Endoscopist's training
Control ArmNo interventionThe endoscopists in the control arm will not be informed about participation in the study and will receive only tailored feedback on adjusted painful colonoscopy rate (practice as usual). They will receive a reminder, that dedicated report on painful colonoscopy rate is provided in the Polish Colonoscopy Screening Program database and they will be monitored for endpoints through Polish Colonoscopy Screening Program database.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Endoscopist adjusted painful colonoscopy rate change

    Endoscopist adjusted painful colonoscopy rate change (pain during colonoscopy) assessed 6 and 12 months after training intervention.

    Measured: assessed 6 and 12 months after training intervention

Secondary outcomes (4)
  1. Endoscopist adjusted painful colonoscopy rate change - pain after colonoscopy

    Endoscopist adjusted painful colonoscopy rate change (pain after colonoscopy) assessed 6 and 12 months after training intervention.

    Measured: assessed 6 and 12 months after training intervention

  2. Adenoma detection rate (ADR)

    Adenoma detection rate - percentage of colonoscopies with at least one adenoma identified.

    Measured: assessed 6 and 12 months after training intervention

  3. Cecum intubation rate (CIR)

    Percentage of colonoscopies with cecum reached.

    Measured: assessed 6 and 12 months after training intervention

  4. Adjusted painful colonoscopy rate for screening centres (in which assessed endoscopists are working)

    Center adjusted painful colonoscopy rate change (pain during colonoscopy) assessed 6 and 12 months after training intervention.

    Measured: assessed 6 and 12 months after training intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2019
  2. Study startNov 2019 (estimated)
  3. Primary completionJun 2020 (estimated)
  4. Study completionJul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04093687
Sponsor's protocol ID
MSCI
Status last verified
Sep 2019
First submitted
15 Sep 2019
Last updated
18 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kaminski MF, Anderson J, Valori R, Kraszewska E, Rupinski M, Pachlewski J, Wronska E, Bretthauer M, Thomas-Gibson S, Kuipers EJ, Regula J. Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial. Gut. 2016 Apr;65(4):616-24. doi: 10.1136/gutjnl-2014-307503. Epub 2015 Feb 10.

    PubMed 25670810

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopist's training in people with Colorectal Cancer, run by Maria Sklodowska-Curie National Research Institute of Oncology at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marek Bugajski, MD, PhD (22-5463-044, marek.bugajski@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Endoscopist adjusted painful colonoscopy rate change (time frame: assessed 6 and 12 months after training intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04093687, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in